| 000 | 01180 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515081250.0 | ||
| 264 | 0 | _c20090504 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1671-4083 | ||
| 024 | 7 |
_a10.1111/j.1745-7254.2007.00698.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeng, Ling-hua | |
| 245 | 0 | 0 |
_aSalvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cSep 2007 |
||
| 300 |
_a1460-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aDNA Damage _xdrug effects |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNaphthoquinones _xpharmacology |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aTopoisomerase II Inhibitors |
| 700 | 1 | _aDing, Jian | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 28 _gno. 9 _gp. 1460-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1745-7254.2007.00698.x _zAvailable from publisher's website |
| 999 |
_c17253223 _d17253223 |
||